ID   CHK1_RAT                Reviewed;         476 AA.
AC   Q91ZN7; Q91ZN6;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Serine/threonine-protein kinase Chk1;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:O14757};
DE   AltName: Full=CHK1 checkpoint homolog;
DE   AltName: Full=Checkpoint kinase-1;
GN   Name=Chek1; Synonyms=Chk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE PROMOTER USAGE,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=11687578; DOI=10.1074/jbc.m108253200;
RA   Shann Y.-J., Hsu M.-T.;
RT   "Cloning and characterization of liver-specific isoform of Chk1 gene from
RT   rat.";
RL   J. Biol. Chem. 276:48863-48870(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Fischer 344;
RA   Wang X., Wang Y.;
RT   "The rat homolog of checkpoint kinase chk1.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Serine/threonine-protein kinase which is required for
CC       checkpoint-mediated cell cycle arrest and activation of DNA repair in
CC       response to the presence of DNA damage or unreplicated DNA. May also
CC       negatively regulate cell cycle progression during unperturbed cell
CC       cycles. This regulation is achieved by a number of mechanisms that
CC       together help to preserve the integrity of the genome. Recognizes the
CC       substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates
CC       CDC25A, CDC25B and CDC25C. Phosphorylation of CDC25A at 'Ser-178' and
CC       'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding
CC       sites for 14-3-3 proteins which inhibit CDC25A and CDC25C.
CC       Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279'
CC       and 'Ser-293' promotes proteolysis of CDC25A. Phosphorylation of CDC25A
CC       at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-
CC       79', 'Ser-82' and 'Ser-88' by NEK11, which is required for
CC       polyubiquitination and degradation of CDCD25A. Inhibition of CDC25
CC       leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin
CC       complexes and blocks cell cycle progression. Also phosphorylates NEK6.
CC       Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the
CC       release of RAD51 from BRCA2 and enhances the association of RAD51 with
CC       chromatin, thereby promoting DNA repair by homologous recombination.
CC       Phosphorylates multiple sites within the C-terminus of TP53, which
CC       promotes activation of TP53 by acetylation and promotes cell cycle
CC       arrest and suppression of cellular proliferation. Also promotes repair
CC       of DNA cross-links through phosphorylation of FANCE. Binds to and
CC       phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent
CC       phosphorylation of the chromatin assembly factor ASF1A. This may
CC       enhance chromatin assembly both in the presence or absence of DNA
CC       damage. May also play a role in replication fork maintenance through
CC       regulation of PCNA (By similarity). May regulate the transcription of
CC       genes that regulate cell-cycle progression through the phosphorylation
CC       of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads
CC       to epigenetic inhibition of a subset of genes (By similarity). May also
CC       phosphorylate RB1 to promote its interaction with the E2F family of
CC       transcription factors and subsequent cell cycle arrest. Phosphorylates
CC       SPRTN, promoting SPRTN recruitment to chromatin (By similarity).
CC       Reduces replication stress and activates the G2/M checkpoint, by
CC       phosphorylating and inactivating PABIR1/FAM122A and promoting the
CC       serine/threonine-protein phosphatase 2A-mediated dephosphorylation and
CC       stabilization of WEE1 levels and activity (By similarity).
CC       {ECO:0000250|UniProtKB:O14757, ECO:0000250|UniProtKB:O35280}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O14757};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:O14757};
CC   -!- ACTIVITY REGULATION: Activated through phosphorylation predominantly by
CC       ATR but also by ATM in response to DNA damage or inhibition of DNA
CC       replication. Activation is modulated by several mediators including
CC       CLSPN, BRCA1 and FEM1B. Proteolytic cleavage at the C-terminus by SPRTN
CC       during normal DNA replication activates the protein kinase activity.
CC       {ECO:0000250|UniProtKB:O14757}.
CC   -!- SUBUNIT: Interacts (phosphorylated by ATR) with RAD51. Interacts with
CC       and phosphorylates CLSPN, an adapter protein that regulates the ATR-
CC       dependent phosphorylation of CHEK1. Interacts with BRCA1. Interacts
CC       with and phosphorylates CDC25A, CDC25B and CDC25C. Interacts with
CC       FBXO6, which regulates CHEK1. Interacts with PPM1D, which regulates
CC       CHEK1 through dephosphorylation. Interacts with TIMELESS; DNA damage-
CC       dependent. Interacts with FEM1B; activates CHEK1 in response to stress.
CC       Interacts with TLK1. Interacts with XPO1 and YWHAZ. Interacts with
CC       CDK5RAP3; antagonizes CHEK1. {ECO:0000250|UniProtKB:O14757}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O14757}.
CC       Chromosome {ECO:0000250|UniProtKB:O14757}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O14757}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:O14757}.
CC       Note=Nuclear export is mediated at least in part by XPO1/CRM1. Also
CC       localizes to the centrosome specifically during interphase, where it
CC       may protect centrosomal CDC2 kinase from inappropriate activation by
CC       cytoplasmic CDC25B. Proteolytic cleavage at the C-terminus by SPRTN
CC       promotes removal from chromatin. {ECO:0000250|UniProtKB:O14757}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q91ZN7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q91ZN7-2; Sequence=VSP_015770;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed in brain, heart, liver,
CC       lung, skeletal muscle, spleen and testis.
CC       {ECO:0000269|PubMed:11687578}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed only in liver.
CC       {ECO:0000269|PubMed:11687578}.
CC   -!- DOMAIN: The autoinhibitory region (AIR) inhibits the activity of the
CC       kinase domain. {ECO:0000250|UniProtKB:O14757}.
CC   -!- PTM: Phosphorylated by ATR in a RAD17-dependent manner in response to
CC       ultraviolet irradiation and inhibition of DNA replication.
CC       Phosphorylated by ATM in response to ionizing irradiation. ATM and ATR
CC       can both phosphorylate Ser-317 and Ser-345 and this results in enhanced
CC       kinase activity. Phosphorylation at Ser-345 induces a change in the
CC       conformation of the protein, activates the kinase activity and is a
CC       prerequisite for interaction with FBXO6 and subsequent ubiquitination
CC       at Lys-436. Phosphorylation at Ser-345 also increases binding to 14-3-3
CC       proteins and promotes nuclear retention. Conversely, dephosphorylation
CC       at Ser-345 by PPM1D may contribute to exit from checkpoint mediated
CC       cell cycle arrest. Phosphorylation at Ser-280 by AKT1/PKB, may promote
CC       mono and/or diubiquitination. Also phosphorylated at undefined residues
CC       during mitotic arrest, resulting in decreased activity (By similarity).
CC       {ECO:0000250|UniProtKB:O14757}.
CC   -!- PTM: Ubiquitinated. Mono or diubiquitination promotes nuclear
CC       exclusion. The activated form (phosphorylated on Ser-345) is
CC       polyubiquitinated at Lys-436 by some SCF-type E3 ubiquitin ligase
CC       complex containing FBXO6 promoting its degradation. Ubiquitination and
CC       degradation are required to terminate the checkpoint and ensure that
CC       activated CHEK1 does not accumulate as cells progress through S phase,
CC       when replication forks encounter transient impediments during normal
CC       DNA replication. 'Lys-63'-mediated ubiquitination by TRAF4 at Lys-132
CC       activates cell cycle arrest and activation of DNA repair (By
CC       similarity). {ECO:0000250|UniProtKB:O14757}.
CC   -!- PTM: Proteolytically cleaved at the C-terminus by SPRTN during normal
CC       DNA replication, thereby promoting CHEK1 removal from chromatin and
CC       activating the protein kinase activity. {ECO:0000250|UniProtKB:O14757}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. NIM1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF414135; AAK98619.1; -; mRNA.
DR   EMBL; AF414136; AAK98620.1; -; mRNA.
DR   EMBL; AF443592; AAL37894.1; -; mRNA.
DR   RefSeq; NP_536325.1; NM_080400.1. [Q91ZN7-1]
DR   RefSeq; XP_008764264.1; XM_008766042.2. [Q91ZN7-1]
DR   RefSeq; XP_008764265.1; XM_008766043.1. [Q91ZN7-1]
DR   AlphaFoldDB; Q91ZN7; -.
DR   SMR; Q91ZN7; -.
DR   BioGRID; 250797; 2.
DR   PhosphoSitePlus; Q91ZN7; -.
DR   PaxDb; 10116-ENSRNOP00000011226; -.
DR   Ensembl; ENSRNOT00000011226.6; ENSRNOP00000011226.4; ENSRNOG00000071217.1. [Q91ZN7-1]
DR   Ensembl; ENSRNOT00055015545; ENSRNOP00055012460; ENSRNOG00055009175. [Q91ZN7-1]
DR   Ensembl; ENSRNOT00060020694; ENSRNOP00060016295; ENSRNOG00060012193. [Q91ZN7-1]
DR   Ensembl; ENSRNOT00065027646; ENSRNOP00065021767; ENSRNOG00065016588. [Q91ZN7-1]
DR   GeneID; 140583; -.
DR   KEGG; rno:140583; -.
DR   UCSC; RGD:620545; rat. [Q91ZN7-1]
DR   AGR; RGD:620545; -.
DR   CTD; 1111; -.
DR   RGD; 620545; Chek1.
DR   eggNOG; KOG0590; Eukaryota.
DR   GeneTree; ENSGT00940000159682; -.
DR   HOGENOM; CLU_000288_59_8_1; -.
DR   InParanoid; Q91ZN7; -.
DR   OMA; GYTCKVG; -.
DR   OrthoDB; 1341507at2759; -.
DR   PhylomeDB; Q91ZN7; -.
DR   TreeFam; TF351441; -.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-RNO-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-RNO-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-RNO-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-RNO-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-RNO-8953750; Transcriptional Regulation by E2F6.
DR   SABIO-RK; Q91ZN7; -.
DR   PRO; PR:Q91ZN7; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000031896; Expressed in jejunum and 18 other cell types or tissues.
DR   ExpressionAtlas; Q91ZN7; baseline and differential.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:RGD.
DR   GO; GO:0000794; C:condensed nuclear chromosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005657; C:replication fork; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035402; F:histone H3T11 kinase activity; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:1902742; P:apoptotic process involved in development; ISO:RGD.
DR   GO; GO:0071313; P:cellular response to caffeine; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0000077; P:DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; ISO:RGD.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0001833; P:inner cell mass cell proliferation; ISO:RGD.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; ISO:RGD.
DR   GO; GO:0044818; P:mitotic G2/M transition checkpoint; ISS:UniProtKB.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; IMP:RGD.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; ISS:UniProtKB.
DR   GO; GO:0045839; P:negative regulation of mitotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0006997; P:nucleus organization; ISO:RGD.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045787; P:positive regulation of cell cycle; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010569; P:regulation of double-strand break repair via homologous recombination; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0046602; P:regulation of mitotic centrosome separation; ISS:UniProtKB.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; IMP:RGD.
DR   CDD; cd14069; STKc_Chk1; 1.
DR   Gene3D; 3.30.310.80; Kinase associated domain 1, KA1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR034670; Chk1_catalytic_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1.
DR   PANTHER; PTHR24346:SF73; SERINE_THREONINE-PROTEIN KINASE CHK1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; ATP-binding; Cell cycle; Chromosome; Cytoplasm;
KW   Cytoskeleton; DNA damage; DNA repair; Isopeptide bond; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..476
FT                   /note="Serine/threonine-protein kinase Chk1"
FT                   /id="PRO_0000085850"
FT   DOMAIN          9..265
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..265
FT                   /note="Interaction with CLSPN"
FT                   /evidence="ECO:0000250"
FT   REGION          267..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..476
FT                   /note="Autoinhibitory region"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        280..329
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        130
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         15..23
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         38
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         280
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:O35280"
FT   MOD_RES         286
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         317
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         345
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35280"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   CROSSLNK        132
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   CROSSLNK        436
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O14757"
FT   VAR_SEQ         1..282
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11687578"
FT                   /id="VSP_015770"
SQ   SEQUENCE   476 AA;  54428 MW;  5635614A3E5B4657 CRC64;
     MAVPFVEDWD LVQTLGEGAY GEVQLAVNRI TEEAVAVKIV DMKRAIDCPE NIKKEICINK
     MLNHENVVKF YGHRREGNIQ YLFLEYCSGG ELFDRIEPDI GMPEQDAQRF FHQLMAGVVY
     LHGIGITHRD IKPENLLLDE RDNLKISDFG LATVFRHNNR ERLLNKMCGT LPYVAPELLK
     RKEFHAEPVD VWSCGIVLTA MLAGELPWDQ PSDSCQEYSD WKEKKTYLNP WKKIDSAPLA
     LLHKILVENP SARITIPDIK KDRWYNKPLN RGAKRPRATS GGMSESSSGF SKHIHSNLDF
     SPINSGSSEE NVKFSSSQPE PRTGLSLWDT GPSNVDKLVQ GISFSQPTCP DHMLVNSQLL
     GTPGSSQNPW QRLVKRMTRF FTKLDADKSY QCLKETFEKL GYQWKKSCMN QVTVSTMDRR
     NNKLIFKINL VEMDEKILVD FRLSKGDGLE FKRHFLKIKG KLSDIVSSQK VWFPVT
//
